These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7761712)
21. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Furuno JP; Metlay JP; Harnett JP; Wilson J; Langenberg P; McGregor JC; Zhu J; Perencevich EN Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):1-9. PubMed ID: 16136615 [TBL] [Abstract][Full Text] [Related]
22. Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily. Bowlware KL; McCracken GH; Lozano-Hernandez J; Ghaffar F Pediatr Infect Dis J; 2006 Mar; 25(3):208-10. PubMed ID: 16511381 [TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999. Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072 [TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections]. Hernández M; Mejía GI; Trujillo H; Robledo J Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923 [TBL] [Abstract][Full Text] [Related]
25. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005. Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469 [TBL] [Abstract][Full Text] [Related]
27. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306 [TBL] [Abstract][Full Text] [Related]
28. The epidemiology of penicillin resistance in Streptococcus pneumoniae. Forward KR Semin Respir Infect; 1999 Sep; 14(3):243-54. PubMed ID: 10501312 [TBL] [Abstract][Full Text] [Related]
30. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Appelbaum PC Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. Jones RN; Fritsche TR; Sader HS Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501 [TBL] [Abstract][Full Text] [Related]
32. Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections. Lister PD Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S18-25. PubMed ID: 7729467 [TBL] [Abstract][Full Text] [Related]
33. [The characteristics of pneumococcal contamination of the respiratory tract in healthy and sick children]. Lomnyts'ka VB; Kolotylova LV; Nemchenko OO; Saad AS; Prun'ko TD; Lutsyk TS Mikrobiol Z; 1995; 57(1):59-63. PubMed ID: 7728276 [TBL] [Abstract][Full Text] [Related]